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I. INTRODUCTION

Since achieving critical mass in 1995, the Internet has clearly
revolutionized modem society. Not only are a wealth of information and
a wide array of interactive applications just a few clicks of a mouse away,
but the web continues to evolve into increasingly refined and focused user
applications. Although forward-looking businesses in every conceivable
industry continue to seek out innovative ways to effectively utilize the
interactive qualities of the Internet, far-sighted organizations are actively
seeking to establish their servers as the principle hubs for various
electronic commercial applications.' In the future, health care institutions
will mix and match best-of-breed, web-based information systems for each
respective informational niche (i.e. practice management, medical records,
laboratory, radiology, claims, etc.) in a "plug-and-play" system
configuration.2 Institutions will select which best-of-breed systems they
want, and through evolving communication standards and protocols, each
of these systems will share information with one another for optimal
networking efficiency.' Simply put, the modem health care industry, like
many other industry segments, stands poised to embrace the innovations
of twenty-first century information technology.
Several newly formed companies, many of which are cash-rich from
recent initial public offerings of stock, are now attempting to establish
electronic pharmacy communication links that would enable electronic
prescribing from an icon within the operating environment of either
browser or software based physician practice management systems. 4
Because there are a finite number of physicians, the battle for market share

1. See Richard C. Howe, The Electronic Connection: PhysiciansFace Imperative to Use
It to Interact With MCOs, MANAGED HEALTHCARE NEWS, Sept. 1999, at 27, 27-28.
2. See Alan Joch, All Aboard!, HEALTHCARE INFORMATICS, Sept. 1999, at 42, 43.
3. See id at 48.
4. See Polly Schneider, Digital Rx, HEALTHCARE INFORMATICS, Feb. 1998, at 40, 40.
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in this emerging industry has become increasingly competitive and will
become even more attractive as the baby-boom population ages and the
number of medications prescribed increases. While the companies that are
establishing pharmacy-related, electronic data interchange (EDI) networks
clearly recognize that they will be able to garner transaction fees from each
prescribed medication that is routed through each of their proprietary
systems, they are also keenly aware that income can be derived from
electronically publishing and updating the formularies (i.e., preferred drug
lists) of health systems and managed care organizations (MCOs).' In fact,
it seems inevitable that the "formulary" system - a concept based entirely
on the notion that all things being equal it is economically advantageous
to prescribe drugs that are cheaper - will over time be recognized as the
backbone of any cost-effective electronic prescribing system.6 The
growing interest in electronic formulary management systems in the
private sector has prompted an increasing number of health care
professionals to begin to question why government health care programs
have not implemented comprehensive electronic formulary management
systems to achieve similar cost savings.7
Considering these facts, the aim of this paper is three-fold: to describe
the American formulary system and the economic efficiencies that can be
realized when physicians comply with a health care institution's or MCO's
formulary, to set forth in detail how the formulary system fits into and
underlies the new environment of seamless health care EDI, and to argue
that congressional legislative action is needed to fully extend the
formulary system to the Medicaid programs in all fifty states. The general
purpose of this paper will be to argue that, within the current environment
of rapid technological innovation in the health care industry, a legislatively
mandated extension of the formulary system to state Medicaid programs
is necessary in order to make the most cost-effective use of taxpayer
monies.

5. See Pamela Tabar, Emerging Business Models: Kinetra, HEALTHCARE INFORMATICS,
Sept. 1999, at 56, 56.
6. See Lawrence B. Lehman, Managing Growing PharmaceuticalCosts: Formularies
Provide Potent Contributionsto Cost Containment,MANAGED HEALTHCARE NEWS, Dec. 1998, at

35,35.
7. See Daniel A. Hussar, Editorial, Its Time to Develop the NationalCommunity Formulary
System, PHARMACY TODAY, Jan. 1998, at 4 (stating that a "National Community Formulary
System" should be created and that the American Pharmaceutical Association and the American
Medical Association should collaborate- presumable with the drafters of hoped for congressional
legislation - to develop and implement the concept). But see Jean Lawrence, Getting Serious
About Formularies,MANAGED CARE, Mar. 1998, at 23, 30 (noting one commentator's observation
that some state and local governments have begun to consider "anti-formulary legislation").
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II. THE FORMULARY SYSTEM
A formulary, or list of preferred drugs, is arguably the most
fundamental method of managing pharmaceutical costs.8 In fact, most
hospitals, health maintenance organizations (HMOs), and prescription
benefit managers (PBMs) in the United States now utilize a formulary as
a means of enhancing cost savings. 9
A. Background
According to a 1998 report issued by the American Medical
Association's Council on Ethical and Judicial Affairs, the formulary
system has become firmly entrenched in the American system of health
care.' ° The report states that:
Formularies derive from formulary systems, a method
whereby the medical staff of an institution evaluates,
appraises, and selects drugs considered to be most useful in
patient care. In most managed care formulary systems, a
pharmacy and therapeutics (P&T) committee is appointed to
review candidates for the formulary, generally considering a
variety of drugs from the same class and selecting the most
cost-effective for inclusion. Physicians participating in the
plan are bound to prescribe drugs from that formulary. If
patients choose to go outside a formulary, they may be
subject to a higher co-payment or may even be held
responsible for the full cost of the prescribed drug.
Physicians can request additions to formularies, and
accommodations can be made in exceptional cases for the
provision of non-formulary drugs. While the percentage of
HMOs that allow for physician overrides of formularies is
increasing, there is little or no data on the percentage of
requests for additions or exceptions that actually are
approved. Managed care plans benefit from adherence to
formulary systems because they can ensure that their patient
care funds are not spent on unnecessarily expensive drugs. In
addition, by ordering fewer drugs at a higher volume per
drug, they can negotiate more favorable terms with the

8. See Christine Dodd, Comment, The Merck-Medco Merger: An Isolated Incident or a
Catalystfor the Transformationofan Industry?, 63 U. CIN. L. REV. 1767, 1774 (1995). PBMs are
specialized insurance companies that focus exclusively on providing prescription drug benefits. See
id. at 1769.
9. See id. at 1774; Lehman, supra note 6, at 35.
10. See Council on Ethical & Jud. Aff. Am. Med. Ass'n, Managed Care Cost Containment
Involving PrescriptionDrugs, 53 FOOD & DRUG L.J. 25, 25 (1998).
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pharmaceutical companies. Indeed, discounts can be as much
as ten percent of a drug's cost. Plans encourage physicians
and plan-affiliated pharmacists to adhere to formularies by
linking their compensation or status in the plan to their
prescribing practices or simply by making it more costly for
patients if physicians deviate from the formulary."
Simply put, the widespread use of P&T committees to develop
formularies, coupled with the concerted efforts to ensure that physicians
and pharmacists comply with plan-specific formularies, has created a
climate in which most health care professionals now recognize that
adhering to a select list of preferred therapeutic 2agents constitutes an
extremely effective cost-containment mechanism.'
B. Types of Formularies:"Open, " "Closed,"
"PartiallyClosed," and "Clinical"
There are several different types of formularies in use today in the
United States, namely, open formularies, closed formularies, partiallyclosed formularies, and clinical formularies. 3 While open and closed
formularies can be considered polar opposites, the partially-closed
formulary attempts to strike a politically palatable middle road between
cost savings and choice. 4 Clinical formularies are unique in that they
constitute diagnosis-specific efforts to achieve cost savings." Viewed in
the aggregate, the formulary system consists of distinguishable tiers, each
of which entails a different level of drug availability.
1. Open Formularies
Under an open formulary arrangement, a health plan will pay for all
drugs whether or not they are on the approved list.'6 Although a health
plan or hospital might informally encourage the use of one specific drug
among equivalent therapeutic agents, official formulary books (listing

11. Id. at 27-28.
12. See Mary E.S. Indritz & Margaret Artz When Cost Is a Consideration: Using Decision
Analysis for Formulary Recommendations, 24 PHARMACY & THERAPEUTICS 368,368 (1999); see
also Inga Heemink et al., Review of the Functioning of P&T Committees in Boston-Area
Hospitals-Part2, 24 PHARMACY & THERAPEUTICS 264, 264 (1999).
13. See Robert P. Navarro, Evidence-Based Drug Formularies: Hyperbole or Reality?,
MANAGED CARE INTERFACE, May 1998, at 63, 63.
14. See id.
15. See id.
16. See Arnold J. Rosoff, The Changing Face of Pharmacy Benefits Management:
Information Technology Pursuesa GrandMission, 42 ST. Louis U. L. J. 1, 11 (1998).
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suggested medications to be used) are not even published or distributed to
prescribing physicians. 7 Because there are no restrictions on available
therapeutic agents, no incentive exists for physicians or pharmacists to
monitor varying drug costs and to substitute the cheapest drug when
several equivalent alternatives are available." From a cost savings
perspective, therefore, having an open formulary is the functional
equivalent of having no formulary at all.' 9
2. Closed Formularies
In stark contrast to open formularies, closed formularies do "not allow
for reimbursement for any nonformulary product"2° and are, therefore,
considered the "most effective strategy"'2! in pharmacoeconomics.22
However, closed formularies are often unpopular due to the limitation on
choice that is being imposed. 23 Although the public may believe that
quality of care and consumer choice (of alternative therapeutic agents) are
being compromised, the prevailing consideration underlying the concept
of the closed formulary is that the selected drugs "are therapeutically
interchangeable and undifferentiated for the overwhelming majority of
patients., 24 To encourage formulary compliance, those entities that
implement closed formularies usually institute some type of price penalty
that gives physicians
and plan members an incentive to adhere to the
25
preferred drug list.

17. See id. (stating that "passive" formularies are wide-open lists of all FDA approved drugs
and implicitly suggesting that it would be unnecessary to communicate formulary information if
the formulary is not a selective list of preferred drugs).
18. See id. at 11. However, PBMs have developed special programs that encourage
pharmacists to persuade physicians to prescribe generic drugs. See id.
19. See id. (stating that "[u]nder an 'open formulary' arrangement, the [health] plan pays for
all drugs whether or not they are on the approved list").
20. See Robert P. Navarro, ElectronicFormulary Control,MED. INTERFACE, Aug. 1997, at
74, 75.
21. Id.

22. "Pharmacoeconomics" is a common term in the pharmacy literature that refers to the
application of economic principles to various aspects of the provision of pharmaceutical care. See
lndritz & Artz, supranote 12, at 368 (discussing how to apply the decision analysis process in order
to "determine the best pharmacoeconomic selection of a drug for formulary addition").
23. See Navarro, supra note 20, at 75.
24. See Navarro, supra note 13, at 64.
25. See Rosoff, supra note 16, at I1.
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3. Partially-Closed Formularies
The notion of a partially-closed formulary seems to be an idea ripe for
development. 26 "Selectively/partially closed formularies typically attack
the top dozen most costly and highly utilized therapeutic categories and
promote those products that have the best quality-cost ratio."27 Although
the percentage of employers choosing health plans with totally closed
formularies grew from 6.3% to 13.3% between 1995 and 1998, the
percentage of HMOs usingpartially-closedformularies grew from 32.6%
to 54.3% over the same three year period.2" The rapid growth of partiallyclosed formularies among HMOs has led one prominent pharmacy
professional to conclude that "[the] greater trend [is] toward
selectively/partially closed drug formularies.,, 29 Ever-conscious of
marginal costs, HMOs, health systems, and PBMs clearly view the
partially-closed formulary as a reasonable and practical means by which
to balance cost-savings and consumer choice."
4. Clinical Formularies
Significantly, the use of clinical formularies has grown a great deal in
recent years.3 Clinical formularies can be either closed or partially-closed
and are organized in relation to particular clinical diagnoses.3 2 Thus, an
HMO could have a clinical formulary for myasthenia gravis, another
clinical formulary for meningitis, and so on for each unique medical
condition. Therefore, within the over-arching movement toward partiallyclosed formularies, clinical formularies constitute an increasingly
prevalent means by which HMOs and health systems are attempting to
better control the cost of pharmaceuticals.33

26. See Navarro, supranote 13, at 64.
27. Id.
28. See id.
29. Id.
30. See Quinn & Barisano, infra note 117, at 1311 (stating that "[m]anaged care companies,
seeking opportunities to gain control of [pharmaceutical costs, have responded by embracing the
formulary system").
31. See generally Robert P. Navarro, Influencing Drug Formulary and Contract
Performance, MANAGED CARE INTERFACE, Apr. 1999, at 90 (discussing the numerous types of
formularies in use and the position a single drug may have in relation to the entire formulary).
32. See id.
33. See id.
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C. The Public'sPerceptionof the FormularySystem
Managed care organizations have routinely been criticized in the
national press for imposing limitations on the general availability of
services and treatment options.34 Within this environment, the area of
formulary implementation has proven no exception. Understandably, the
public has reacted somewhat skeptically to the process of formulary drug
selection." The "Right to Know" campaign in California is just one
noteworthy example of a private initiative that aims to force health3 plans
6
to make plan-specific formulary data better available to the public.
In situations where physicians specifically call for the use of offformulary medications, however, the fact that an MCO may charge a
higher co-payment or that a health plan would outright refuse to pay for a
particular therapeutic medication should not be wholly unexpected.
Although it is only natural that people will want to know what medications
their health plan will cover, health plan members surely can understand
that an MCO's financial viability, let alone long-term profitability,
depends entirely on effectively controlling marginal costs." After all,
MCOs are market actors and must contend with market forces. The
challenge for P&T committees, therefore, is not only to communicate to
prescribing physicians what drugs are on a particular formulary, but also
to effectively communicate to the public it serves that the cost of
pharmaceuticals is a highly relevant factor that affects the bottom-line
prescription benefit the plan is able to offer.3"

34. See, e.g., Charles Bierbauer, PrescriptionSoughtforPerfect Health CaseSystem (visited
Dec. 17, 1999) <http://www.cnn.com/HEALTH/9907/15/patients.rights/> (discussing the
widespread popular discontent with the healthcare system in the United States); Eileen O'Connor,
HMO Debate: What's In It for You? (visited
Dec.
17,
1999)
<http://www.cnn.com/HEALTH/9907/12/patients.rights/> (noting that the denial of necessary
medical treatment by cost-conscious HMOs often has serious consequences for the individual with
the untreated medical condition); Higher Health Insurance Costs, Fewer Restrictions Greet
Workers (visited Dec. 17, 1999) <http://www.cnn.com/HEALTH/9911/28/insurance.ap/> (stating
that both consumer demand for more flexible health plans and the escalating cost of prescription
drugs are two reasons why HMO premiums have risen so fast).
35. See Lawrence, supra note 7, at 23.
36. See Congress to Consider Federal 'FormularyRights'Bill, FORMULARY, Jan. 2000, at
27. Having helped pass mandatory formulary disclosure legislation in California, the "Right to
Know" organization is now supporting a similar legislative provision offered at the federal level.
Id.
37. See Lehman, supra note 6, at 35.
38. See infra note 119 and accompanying text.
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III.

FORMULARIES AND THE NEW BREED OF E-PHARMACY
INFORMATION SYSTEM

The Internet presents the ultimate opportunity to establish a universally
accessible, standardized platform for the cost-effective, timely, and
accurate transfer of sensitive pharmaceutical information. At present,
however, the medical industry is dominated by propriety intranetsystems
that do not interface easily with outside computer networks.39 The latest
trend is for intranet systems to converge in value-added-networks (VANs)
with a new focus on interfacing with the Internet.40 As health care intranets
increasingly interface with outside networks, the obvious
trend will be to
4
utilize the Internet as the ultimate standardized VAN. '
Although at present many users of the Internet merely "browse" the
web in efforts to explore what sort of information is available (much like
channel surfing on television), today's "browser culture" over time will be
eclipsed by much more focused and refined user applications. 42 The
Internet is the natural medium for the large-scale and timely
communication of valuable health care information in an intense workplace environment where system accessibility and functionality are the
primary concern. 43 Accordingly, several companies are now actively
attempting to establish holistic, integrated web systems that will bridge
communications from both professionals and patients to pharmacies at the
precise moment that critical decisions are made and executed." These
companies are currently experimenting with both the format by which
information is presented and accessed, as well as the method by which
data is manipulated within the context of pre-existing information
systems.45 The more innovative and ambitious companies aspire to provide
relevant, real-time information to health care providers and consumers

39. See generallyInteroperabilityProjectTests HCFA 'sInternetPolicyin the PrivateSector,
IT HEALTH CARE STRATEGIST (Aspen Publishers, Inc., Gaithersburg, MD), July 1999, at 3, 4.
40. See id. Implicit in the concept of interoperability is the idea that value is being added to
create a more functional and streamlined information network.
41. See id.
42. See generally Gordon D. Schiff & T. Donald Rucker, Computerized Prescribing:
Building the Electronic Infrastructurefor Better Medication Usage, 279 JAMA 1024 (1998)
(stating that "[c]omputerized prescribing in the practice of medicine is long overdue").
43. See id at 1027 (stating that "[c]omputerized prescribing restructures the way scientific
and treatment information is used and the way health professionals work").
44. See generally Healtheon to Buy Rival (visited Feb.
14, 2000)
<http://cgi.cnnfn.com/output/pfv/2000/02/14/deais/healtheon/> (noting the market efforts of
Healtheon/WebMD Corp. and Carelnsite Inc., two prominent competitors in this industry segment
that recently announced plans to merge).
45. See id.
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alike.46
A. Key Elements of an E-PharmacyInformation System
The ideal e-pharmacy information system would feature an array of
proprietary channels (i.e., icons) providing relevant, interactive health care
applications to physicians, patients, pharmacies, pharmacists, managed
care organizations, and pharmaceutical manufacturers.47 Foremost among
these applications, the system would permit system users to access 48a
comprehensive compendia of electronically-maintained formularies,
enable physicians to write and send formulary-compliant scripts to
pharmacies over the Internet,49 allow patients to utilize the Internet to
request refills directly from their pharmacies, 0 and provide a centralized
mechanism by which pharmacies will be able to retrieve both prescription
orders and refill requests. 5'
1. Electronic Formulary Publishing and Maintenance
Formularies are becoming essential to a health care system's efforts to
produce favorable outcomes at competitive costs.52 Because formulary
compliance is emerging as a major focus for pharmaceutical services in
health care systems across the nation, the ability of health care
professionals to access and review a health care institution's formulary
will only increase in importance in the future.53
Traditionally, formularies have been published in booklets that have
been distributed by P&T committees to prescribing physicians either
annually or semi-annually. 4 The problem with this paper-based method is
two-fold. First, the formulary information becomes outdated very quickly
46. See id.
47. See Joch, supra note 2, at 44. (noting that 1) "[p]harmaceutical companies need ebusiness as a direct marketing pipeline to doctors and to increase their growing efforts to market
directly to consumers," that 2) "[m]ergers and acquisitions have made easy communications among
doctors, labs, administrators, insurers, and clearing houses nearly impossible," and that 3) "get[ting]
everyone talking again" should be a primary information technology objective as it relates to
healthcare").
48. See Schneider, supra note 4, at 40.
49. See id.
50. But see Carol Ukens, Taming the Wild West: State Boards Turn Wary Eye to Internet
Pharmacies, DRUG TOPiCS, Apr. 20, 1998, at 112, 112.
51. See Schneider, supra note 4, at 41.
52. See Navarro, supra note 20, at 74.
53. See id. at 76.
54. See American Society of Hospital Pharmacists, Statement on the FormularySystem, 40
AM. J. HosP. PHARMACY 1384, 1385 (1983) (stating that "[clopies of the formulary must be readily
available and accessible [by health care providers] at all times").
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due to frequent changes in preferred drugs. Second, the booklets are often
either misplaced or simply not consulted. The challenge, therefore, is to
use information technology to fit the practice of formulary maintenance
into the prescribing physician's clinical workflow.
An ideal formulary management system would not be a static list of
data isolated from other complementary information system applications"
but would be "seamlessly integrated into the workflow process of seeing
and processing patients." 6 Such a system would enable physicians to
request specific therapeutic agents be added to a particular institution's
formulary, as well as allow third-party payers to use the system to conduct
a pro-active, drug utilization review (DUR)."
2. Electronic Prescription Writing"
Electronic prescribing is the natural complement to electronic
formulary maintenance.59 The web browser, also known as a "universal
client," is quickly becoming a standard feature of desktop PCs, and
software vendors specializing in physician office practice management
increasingly have begun to incorporate universal client technology into the
operating environment of their medical software packages.6" Therefore,
physicians can access an e-pharmacy information system by interfacing
with a particular Internet address (i.e., www.epharmacy.com) from either
a freestanding browser or a specific software vendor's proprietary shell
menu.6 The Internet now enables physicians to electronically write and
send prescriptions, which have been automatically checked for their

55. For an example of a stand-alone, electronically published formulary, see the University
of Missouri
hospital formulary
posted
and maintained
at
<www.hsc.missouri.edu/formulary/index.html>.
56. Navarro, supra note 20, at 75.
57. See id. (stating that "[t]he problem with most [formulary] tactics is that they are
retrospective in nature and attempt to change a nonformulary prescription after the patient has left
the physician").
58. See Healtheon to Buy Rival, supra note 44 (providing an assessment of the major
commercial players in the market for electronic prescription writing services); see also Schiff &
Rucker, supra note 42, at 1024 (stating that "[p]hysicians should never again write a prescription
... [i]nstead, all medications should be prescribed on a computer").
59. See Schneider, supra note 4, at 40.
60. See id.
61. A "fat client" is defined as "a client machine [in a client/server architecture] that performs
most or all of the processing, with little or none performed by the server. The client handles
presentation and functions, and the server manages data and access to it." MICROSOFT COMPUTER
DICTIONARY 179 (4th ed. 1999). Conversely, a "thin client" is defined as "a network device [in a
client/server architecture] that has the ability to process information independently but relies on
servers for applications, data storage, and administration." Id. at 441.
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formulary compliance, from anywhere Internet access is available to
potentially any pharmacy in the world.
3. Electronic Refill Requests
While two billion original prescriptions were written by physicians in
1998 alone, an additional six hundred million refill requests were
submitted by consumers directly to pharmacies.62 Therefore, a
comprehensive e-pharmacy information system will allow health care
consumers (i.e., patients) to submit prescription refill requests from their
homes to the pharmacy of their choice.63 A refill order submitted via the
Internet could be picked up at the pharmacy by the patient in person or
mailed to the patient's home address.' Although Internet refill modules
have developed in isolation from those information systems targeting
physicians, strategic relationships will likely evolve between those
companies serving physicians and those companies targeting patients, and
a hybridization of business models will occur over time.65
4. Electronic Prescription Retrieval
As with physician practice management software programs, over time
pharmacies will inevitably obtain easy access to the Internet through
universal client technology. Both prescriptions originating from physicians
and refill orders sent by consumers will be routed directly to a web-based
repository, which retail pharmacies will be able to access in order to
retrieve and fill incoming prescriptions. By reducing telephone calls and
other time-consuming tasks, pharmacists will be able to increase
operational efficiency and spend more time filling orders and
communicating with patients over the Internet.
B. Beneficiariesof E-Pharmacy
An ideal e-pharmacy information system would target and provide
benefits to a number of user groups. Physicians would use the system to
write formulary-compliant scripts and send them directly to pharmacies,
to access and suggest updates to a health care institution's formulary, and

62. See Schiff & Rucker, supra note 42.
63. But see Michael A. Sjuggerud, http://www.prescription-drugs.com 3-8 (July 1999)
(unpublished manuscript, on file with author) (describing the regulatory challenges that must be
overcome as the Internet drugstore market develops).
64. See Carol Ukens, Internet Pharmacies,DRUG Topics, May 17, 1999, at 63, 63.
65. See id. Having recently completed several high-profile strategic partnerships and
numerous rounds of equity financing, Drugstore.com, PlanetRx, and Soma.corn have positioned
themselves as the market leaders in the emerging mail order pharmacy arena. See id.
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to obtain information relating to continuing education.66 Patients would use
the system to send a prescription refill request directly to the pharmacy of
their choice and obtain online information from their pharmacist.67
Pharmacies would use the system to retrieve scripts and refill requests.68
Third-party payers would use the system not only to monitor drug
utilization and obtain information regarding drug outcomes and disease
management, but also to process claims submitted by heath care
providers.69 In addition, pharmaceutical manufacturers could use such a
system to market their products to key decision makers and consumers in
a highly interactive format.70
IV.

RECOMMENDATION: APPLY ELECTRONIC FORMULARY
MANAGEMENT TO STATE MEDICAID PROGRAMS

As private sector market participants refine and advance their
individualized e-pharmacy business models, policy analysts concerned
with public sector fiscal responsibility have increasingly begun to explore
avenues by which government-sponsored health care programs similarly
can harness the economic efficiencies afforded by modem information
technology. 7 ' Specifically, the widespread implementation of formulary
systems in the commercial health care arena, coupled with the emerging
consensus that the Internet over time will become the standardized
platform by which critical health care information is accessed and shared,
strongly suggests that state Medicaid programs can achieve significant cost
savings by implementing electronically managed formularies.72 The final
portion of this paper discusses both the economic possibilities and political
pitfalls inherent in the proposition that states should be required to
electronically maintain formularies for their Medicaid programs.

66. See Schneider, supra note 4, at 40.
67. See id
68. See id. at 41.
69. See id. at 41-42.
70. See Joch, supra note 2, at 44 (stating that "[p]harmaceutical companies need e-business
as a direct marketing pipeline to doctors and to increase their growing efforts to market directly to
consumers").
71. See Elizabeth L. Mitchell, The PotentialforSelf-Interested Behaviorby Pharmaceutical
Manufacturers Through Vertical Integration With PharmacyBenefit Managers: The Need for a
New Regulatory Approach, 54 FOOD & DRUG L.J. 151, 152 (1999).
72. See id.
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A. Medicaidand MedicareProgramBasics
The origin of the joint state/federal Medicaid program is linked very
closely to the origin of the wholly federal Medicare program. 3 One legal
scholar has pointed out that,
[i]n 1966, the federal government enacted the Medicare and
Medicaid statutes which were designed to finance medical
care for the aged and very poor. Rather than providing direct
funds to improve and expand public clinics and hospitals,
Medicaid and Medicare provided the poor and elderly with a
source of payment for private medical care. The programs
promised that the publicly insured poor would have freedom
to choose providers. In theory, Medicaid and Medicare
together would end dual-track medicine by giving poor
people access to private practitioners and private hospitals.
Moreover, the infusion of new Medicaid and Medicare
dollars would enable public hospitals to improve the care
provided the poor and to compete for privately insured
patients.74
At present, thirty-six million low-income individuals receive physician,
hospital and drug assistance under Medicaid," while another thirty-eight
million citizens over the age of sixty-five receive physician and hospital
benefits from Medicare.76
From an economic standpoint, the heavy cost of financing both
Medicaid and Medicare remains an extremely pressing political issue
thirty-three years after the Johnson Administration first introduced its
"War on Poverty" legislation. 77 While the federal government's share of
Medicaid payments were $108 billion in fiscal year 1999 (a 7% increase
over fiscal year 1998),71 Medicare outlays were $224.7 billion for the same
period and are expected to rise 26% over the next five years.79 Considering
the sheer size of the two programs, it is no surprise that scores of

73. See Sidney D. Watson, Medicaid Physician Participation:.Patients, Poverty, and
Physician Self-Interest, 21 AM. J.L. & MED. 191, 195 (1995).
74. See id.
75. See Mitchell, supra note 71.
76. See id.
77. See CLARKE E. COCHRAN ET AL., AMERICAN PUBLIC POLICY 277 (4th ed. 1993).
78. See The Dep 't of Health & Human Services FiscalYear 1999 Medicaid Budget (visited
Oct. 25, 1999) <http://www.hhs.gov/progorg/asmb/budget/fy99budget/pdffiles/hcfa3.pdf>.
79. See The Dep 't of Health & Human Services FiscalYear 1999 Medicare Budget (visited
25,
1999) <http://www.hhs.gov/progorg/asmb/budget/fy99budgetpdffiles/hcfa2.pdf>.
Oct.
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incremental policy changes have been offered over the years by legislators
aiming to curtail spending growth in the health care entitlement arena.8"
B. PrescriptionDrug Coverage:Medicaid
and Medicare Differentiated
Forty-four percent of all prescriptions written annually are for
Medicaid and Medicare program participants." But while Medicaid covers
prescription drugs, Medicare generally does not. 2 This distinction is
highly significant because a formulary cannot be implemented for
Medicare as long as prescription drugs are not part of the overall benefit
package. 3 Although Medicare formularies were proposed as an element
of President Clinton's failed 1993 health care initiative (which called for
a Medicare prescription drug benefit), at present, any discussion about
implementing a national formulary for Medicare is premature and
unwarranted?'
C. The Price ControlAlternative
Theoretically, Congress simply could pass a best price requirement
mandating that pharmaceutical manufacturers not sell drugs to anyone at
a lower price than they are willing to give to the various state Medicaid
programs. If a broad-based price control measure of this nature were
applied across the board to Medicaid, it clearly would be unnecessary to
require states to implement Medicaid formulary systems. While it is
always possible that political support for pharmaceutical price controls
could reach a critical mass at some point over the long term, widespread
resistance to the idea by legislators beholden to pharmaceutical interests
will likely preclude the implementation of such a measure in the
foreseeable future. 5 Considering that the Department of Veterans Affairs,
a major government department, strictly adheres to its own variant of a

80. See COCHRAN ET AL., supra note 77, at 284.
81. See Mitchell, supra note 71.
82. See id.; see also Brooks Jackson, Paying for PrescriptionDrugs Worries Medicare
1999)
25,
Oct.
(visited
Recipients
<http://www.cnn.com/allpolitics/stories/1999/03/1 6/j ackson.prescriptionst>.
83. See Clinton Drops Medicare Prescription Drug Change (visited Oct. 25, 1999)
<http://www.cnn.com/health/9906/26/clinton.medicare> (discussing a recent and noteworthy
presidential effort to implement a prescription benefit for Medicare).
84. See R. Goldberg, AARP HandsMembers a Poison Pill, WALL ST. J., Aug. 16, 1994, at
A12.
85. See MURRAY L. WEIDENBAUM, BuSINESS, GOVERNMENT, AND THE PUBLIC 31 (4th ed.
1990) (describing the role special interests play in the American political process).
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partially-closed formulary system, 6 as well as the general extent to which
price control measures are disfavored in the American economy, the idea
of implementing a preferred drug list for Medicaid seems to be a much
more politically attractive and economically palatable policy alternative.87
D. The Importance of the 1993 Omnibus ReconciliationAct
With the passage of the Omnibus Reconciliation Act of 1993 (the
"Act"), Congress took a large step in the direction of requiring state
Medicaid programs to implement formularies.88 While not mandating their
use, the Act specifically permittedstates to adopt formularies as a method
of containing Medicaid expenditures. 9 Not only have twenty-two states
chosen to adopt some form of preferred drug formulary for Medicaid since
the Act's passage,9 but "forty-six states are [also] moving into or
exploring shifting their Medicaid programs into managed care."9 '
Although the National Association of Chain Drug Stores predicts that most
state Medicaid programs will eventually use a PBM to administer their
prescription benefits, congressional legislation requiring states to
implement Medicaid formularies would seem to constitute an equally
effective means of bringing a private sector cost-savings solution to bear
upon a $108 billion federal program. 92
E. Key Legislation in Florida(HB 1927)
As one of the twenty-eight states without a Medicaid formulary, the
State of Florida recently considered whether it should adopt a partiallyclosed preferred drug list as a means of achieving health-related cost
savings.93 Recognizing that $7 billion of Florida's $45 billion budget
86. Enrollment - Provision of Hospital and Outpatient Care to Veterans, 64 Fed. Reg. 54,
207, 54, 211 (1999) (to be codified at 38 C.F.R. § 17) (1999).
87. See Hussar, supra note 7, at 4.
88. See Omnibus Budget Reconciliation Act, Pub. L. No. 103-66, 107 Stat. 312 (1993).
89. See id.
90. H. Stephen Brown, Remarks at a Conference Entitled "E-Pharmacies '99: The Future
Impact of the Internet on the Pharmaceutical Industry" (Aug. 10, 1999). Mr. Brown is a partner
with the Bogatin Law Firm in Nashville, Tennessee, and serves as counsel to PlanetRx, the online
pharmacy that recently completed an initial public offering of stock. The author attended the EPharmacies conference held in San Francisco, California.
91. See Mitchell, supra note 71, at 151 n.12.
92. See id.
93. See Memorandum from Ruben J. King-Shaw, Jr., Executive Director, Agency for Health
Care Administration, to Kenneth Plante, Legislative Affairs Director, Office of the Governor 1-3
(May 13, 1999) (on file with the author). The memo, entitled "1999 Bill Analysis & Economic
Statement," sets forth the Agency for Healthcare Administration's favorable review of HB 1927
Enrolled and recommends that Governor Bush sign the measure into law. See id. Significantly, the
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94
(15.6% of the annual budget) is spent on Medicaid expenditures alone,
the Florida House of Representatives passed a compromise bill that called
for the creation of an advisory panel and planning committee to "study and
evaluate practitioner prescribing patterns and develop recommendations
for additional prescription drug management techniques." 95 Specifically,
HB 1927 authorized the Agency for Health Care Administration (AHCA)
to "require practitioners who are prescribing inappropriately or
inefficiently, as determined by AHCA, to have their prescribing of certain
drugs subject to prior authorization... [and directed AHCA to] develop
educational interventions designed to promote the proper use of
medications by providers and beneficiaries. 96 In short, the "Medicaid
Formulary Study Panel" was to evaluate current treatment guidelines (in
consultation with the current Drug Utilization Board) and make an official
recommendation on the advisability, feasibility, and cost-effectiveness of
instituting a Medicaid formulary. 97
When the panel's recommendation ultimately was issued on March 3,
2000, the nine member panel not surprisingly voted six to three "not to
recommend the adoption of any type of preferred drug list for the Florida
Medicaid prescribed medicine program. 98 Although Florida Governor Jeb
Bush favored the implementation of a partially-closed formulary and had
indicated that such a measure could save the state as much as $240 million
a year, 99 it is particularly telling that neither HB 1927 nor the panel's final
report made significant reference to the possibility of electronically
publishing a future state Medicaid formulary.' 00 It seems, therefore, that
both the supporters of the bill and the members of the Medicaid Formulary
Study Panel either did not fully appreciate the power of information
technology when applied to the possible creation of a Medicaid formulary

memo notes that the "prescribed medic[ation] category has grown to the point at which current
estimates for FY 1999-2000 for the Medicaid program contain an increase of 30 percent for the
prescribed medicine category over the FY 1998-99 appropriation." Id.
94. See id. at 4-5.
95. Terri W. Fuller, HB 1927 Legislative Bill Analysis, at 42 (May 11, 1999) (unpublished
manuscript, on file with the author).
96. Id.at 46.
97. See Medicaid Formulary Study Panel (visited on Nov. 11, 1999)
<http://www.fdhc.state.fl.us/medicaid/Formulary/mfsp.htm>. The web site for the Medicaid
Formulary Study Panel contains a statement of purpose, aschedule of meetings, minutes from past
meetings, and a list of panel members.
98. FLORIDA MEDICAID PRESCRIBED DRUG PROGRAM: A FINAL REPORT TO THE GOVERNOR,

March 3, 2000, at 3.
99. See LawmakersApprove MedicaidAuthorizationDrugPackage, FLORIDA HEALTHTRAC,
May 1999, at 7.
100. See Fuller, supra note 95, at 2-3; see also FLORIDA MEDICAID PRESCRIBED DRUG
PROGRAM: A FINAL REPORT TO THE GOVERNOR, March 3, 2000, at 1-3, 133.
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or quietly dismissed the concept of electronic formulary maintenance as
too unfeasible, complicated, and futuristic. While the truth probably lies
somewhere in between, it seems clear that the fundamental idea of using
technology to achieve cost savings was not a compelling priority
throughout the panel's decision making process.
F. PoliticalResistance: Floridaas a Barometer
for the Possibilityof CongressionalAction
In Florida, opposition to the idea of implementing a Medicaid
formulary came from two primary sources, physicians and pharmaceutical
companies.'' While Governor Bush's original proposal called for the
outright implementation of a Medicaid formulary and would have required
physicians to obtain prior authorization to prescribe more costly drugs
when a less expensive alternative was available,0 2 "the Florida Medical
Association (FMA) and others ...adamantly opposed the idea saying it
was unduly burdensome."'0 3 Similarly, pharmaceutical companies were
naturally opposed to the idea of a Medicaid formulary because granting
preferential treatment to one manufacturer necessarily meant that other
manufacturers would be excluded."t 4
Interestingly, as the debate over adopting a state Medicaid formulary
continued, physicians and pharmaceutical companies could have cited, to
their advantage, a University of Utah School of Medicine study that found
that "presence of restrictive formularies corresponded to greater use of
health care services resulting from longer duration of illness and more ER
and physician visits."' ' Although the Utah study was not injected into the
debate in Florida, HB 1927 seemed to constitute an effort by the Florida
House to put off confronting an unpopular, incremental policy change by
establishing a panel of experts to further study the matter.
Although the Medicaid Formulary Study Panel did not recommend
adopting a Medicaid formulary in Florida, it is quite clear that the same

101. See LawmakersApprove MedicaidAuthorization Drug Package,supra note 99, at 7. In
Florida, there has been surprisingly little resistance from groups of consumers of healthcare
services. See id. This would likely have changed if the Florida Medicaid Formulary Panel had
recommended adopting a preferred drug list for Medicaid.
102. See id.
103. Id; see also ProposedManagedCare StandardsStress Needfor Flexible Formularies,
32 FORMULARY 1206, 1206 (Dec. 1997) [hereinafter Proposed Managed Care] (noting the
California Medical Association's strong opposition to the use of restrictive formularies).
104. See ProposedManagedCare,supranote 103, at 1206 (noting that drug companies often
control PBMs and use them to protect their financial interests).
105. See Lawrence, supra note 7, at 26 (noting that- among other problems -the Utah study's
methodology was flawed because there was no baseline data and the sample size was too small).
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political pressures occurring at the state level would be greatly magnified
if legislation were introduced in Congress requiring the states to
implement electronic Medicaid formularies as a condition for receiving
federal funds.'06 Considering the difficulties President Clinton has had in
recent months in advocating a prescription benefit for Medicare," 7 as well
as the general anti-managed care sentiment that has proliferated in recent
years, any federal legislation calling for mandatory Medicaid formularies
(let alone electronically maintained formularies) surely would be
characterized as an unnecessary limitation of therapeutic options and a
further erosion of patient autonomy. 108
As of this writing, Congress is preparing to consider passage of H.R.
3274, a bill that has been termed the Formulary Rights Act of 1999 (the
"Act"). 10 9 The Act, which was introduced by Rep. Luis Gutierrez last
November and is now being refined by a House sub-committee, is
modeled after a California bill that was enacted last year."0 The measure
would "give patients greater access to medications exactly as prescribed
and require full disclosure of formulary policies" by entities utilizing
preferred drug lists."' While an alliance of health care organizations and
consumer groups called Citizens for the Right to Know has vocally
supported the idea to require full disclosure of formulary information," 23
the bill is also significant for what it does not propose to accomplish."
Specifically, Rep. Gutierrez's laudable effort to require formulary
information be made available to the public falls far short of requiring
state Medicaid programs to implement preferred drug lists." 4 By focusing
on how formulary information is communicated to the public, the bill fails
to address the best possible method of cost-effectively managing the
106. The author worked in the Washington, D.C. office of a U.S. senator and personally
responded to the volumes of mail produced by special interests such as the American Association
of Retired Persons (AARP).
107. See Clinton Speech Draws Battle Lines Over Medicare Drug Benefit, (visited Nov. 11,
1 999)
[hereinafter
Clinton
Speech]
<http://www.cnn.com/allpolitics/stories/1999/10/25/clinton.medicare/>.
108. See id.
109. See Congressto ConsiderFederalFormularyRights Bill, 35 FORMULARY 27, 27 (2000).
110. See id.
111. Id.
112. See id.
113. See id. The bill would require MCOs to: I) fully disclose information related to
formulary practices; 2) notify enrollees of"any formulary changes;" 3) allow enrollees to "continue
on currently prescribed medications even ifthey are deleted from the formulary;" 4) notify enrolles
of "payment practices for non-formulary medications;" and 5) enable enrollees to have "access to
medications under 'dispense as written' language in spite of any therapeutic substitution policies."
Id.
114. See id.
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substantive formulary content. As such, the bill seems to constitute more
of a public relations effort intended to allay consumer fears about the
possibility of medication options being limited than a bold move in the
direction of renewed cost-consciousness. The bill is laudable as far as it
goes, but it simply does not go far enough.
Because the issue of formulary management is somewhat complicated
and is often misunderstood by consumers of health care services (i.e.,
constituents and voters), it seems likely that Congress will continue merely
to allow states to implement formularies if they so desire." 5 By passing the
buck to the states, members of Congress please both the pharmaceutical
and physician lobbies, while preserving the potential for cost savings to
ultimately be achieved. Therefore, while the idea of requiring states to
implement formularies has not been entirely rejected by Congress, it has
not been enthusiastically embraced either." 6 Unfortunately, it does not
appear that the idea will attain any degree of political momentum at the
federal level any time soon.
V. CONCLUSION

Congress should enact legislation that requires states to implement
formularies for their Medicaid programs as a condition for receipt of
federal Medicaid funds. In the absence of congressional action, the twentyeight states that have not adopted partially-closed Medicaid formularies
should do so in order to help ensure that taxpayer dollars are spent wisely.
A modest incremental policy change of this nature neither rations patient
care nor compromises the overall quality of care, and has proven an
effective means of controlling health care expenditures. 7 Moreover, while
political resistance may prevent Congress and the states from requiring
formularies to be maintained electronically in the near term, the idea of
publishing formularies on the Internet and integrating formularies into
databases supporting electronic prescribing applications undoubtedly will
become an obvious cost savings solution as the number of physicians
utilizing electronic prescribing tools increases."' Although lawmakers at

115. See Clinton Speech, supra note 107.
116. See id.
117. See Campion E. Quinn & Anthony Barisano, Understanding, Creating, and Working with
Formulary Systems, 5 THE AM. J. OF MANAGED CARE 1311, 1311-12 (1999) (noting that
"formularies have been in use for several hundred years" and that "[flormularies exist to manage
the cost of pharmaceutical care and increase the quality of that care").
118. See Ed Rabinowitz, Will Palm-Size Computers Make Electronic Prescribing Happen?,
MANAGED CARE, Oct. 1999, at 59, 61 (pointing out that there are 650,000 practicing physicians in
the United States and reporting one commentator's view that electronic prescription writing
technology "means improved formulary compliance").
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both the federal and state level have a responsibility to support the
development of the information infrastructure underlying our health care
system when it is possible to achieve extraordinary public sector cost
savings, whether states will be required to adopt electronically maintained
Medicaid formularies ultimately will be directly related to the prevailing
political climate and the degree of resistance offered by the physician,
pharmaceutical, and consumer lobbies." 9
VI. APPENDIX
American Society of Hospital Pharmacists
Statement on the FormularySystem 20
Preamble
The care of patients in hospitals and other health-care facilities is often
dependent on the effective use of drugs. The multiplicity of drugs available
makes it mandatory that a sound program of drug usage be developed
within the institution to ensure that patients receive the best possible care.
In the interest of better patient care, the institution should have a
program of objective evaluation, selection, and use of medicinal agents in
the facility. This program is the basis of appropriate, economical drug
therapy. The formulary concept is a method for providing such a program
and has been utilized as such for many years.
To be effective, the formulary system must have the approval of the
organized medical staff, the concurrence of individual staff members, and
the functioning of a properly organized pharmacy and therapeutics (P&T)
committee of the medical staff. The basic policies and procedures
governing the formulary system should be incorporated in the medical
staff bylaws or in the medical staff rules and regulations.
The P&T committee represents the official organizational line of
communication and liaison between the medical and pharmacy staffs. The
committee is responsible to the medical staff as a whole, and its
recommendations are subject to approval by the organized medical staff
as well as to the normal administrative approval process.

119. See FLORIDA MEDICAID PRESCRIBED DRUG PROGRAM: A FINAL REPORT TO THE
GOVERNOR, supra note 98 (including a letter from the president of the American College of
Gastroenterology to the director of the Florida Agency for Health Care Administration outlining
physician resistance to the idea of implementing a preferred drug list, as well as a report by state
Senator William G. "Doc" Myers, M.D., addressing some of the concerns of the pharmaceutical
industry).
120. See American Society of Hospital Pharmacists, supra, note 54, at 1384.
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This committee assists in the formulation of broad professional policies
relating to drugs in institutions, including their evaluation or appraisal,
selection, procurement, storage, distribution, and safe use.
Definition of Formularyand FormularySystem
Theformulary is a continually revised compilation of pharmaceuticals
(plus important ancillary information) that reflects the current clinical
judgment of the medical staff.
The formulary system is a method whereby the medical staff of an
institution, working through the P&T committee, evaluates, appraises, and
selects from among the numerous available drug entities and drug products
those that are considered most useful in patient care. Only those so
selected are routinely available from the pharmacy. The formulary system
is thus an important tool for assuring the quality of drug use and
controlling its cost. The formulary system provides for the procuring,
prescribing, dispensing, and administering of drugs under either their
nonproprietary or proprietary names in instances where drugs have both
names.
GuidingPrinciples
The following principles will serve as a guide to physicians,
pharmacists, nurses, and administrators in hospitals and other facilities
utilizing the formulary system:
1. The medical staff shall appoint a multidisciplinary P&T committee and
outline its purposes, organization, function, and scope.
2. The formulary system shall be sponsored by the medical staff based on
the recommendations of the P&T committee. The medical staff should
adapt the principles of the system to the needs of the particular
institution.
3. The medical staff shall adopt written policies and procedures governing
the formulary system as developed by the P&T committee. Action of
the medical staff is subject to the normal administrative approval
process. These policies and procedures shall afford guidance in the
evaluation or appraisal, selection, procurement, storage, distribution,
safe use, and other matters relating to drugs and shall be published in
the institution's formulary or other media available to all members of
the medical staff.
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4. Drugs should be included in the formulary by their nonproprietary
names, even though proprietary names may be in common use in the
institution. Prescribers should be strongly encouraged to prescribe
drugs by their nonproprietary names.
5. Limiting the number of drug entities and drug products routinely
available from the pharmacy can produce substantial patient-care and
(particularly) financial benefits. These benefits are greatly increased
through the use of generic equivalents (drug products considered to be
identical with respect to their active components; e.g., two brands of
tetracycline hydrochloride capsules) and therapeuticequivalents (drug
products differing in composition or in their basic drug entity that are
considered to have very similar pharmacologic and therapeutic
activities; e.g., two different antacid products or two different
alkylamine antihistamines). The P&T committee must set forth policies
and procedures governing the dispensing of generics and therapeutic
equivalents. These policies and procedures should include the
following points:
That the pharmacist is responsible for selecting, from
available generic equivalents, those drugs to be dispensed
pursuant to a physician's order for a particular drug product.
That the prescriber has the option, at the time of prescribing,
to specify the brand or supplier of drug to be dispensed for
that particular medication order/prescription. The prescriber's
decision should be based on pharmacologic or therapeutic
considerations (or both) relative to that patient.
That the P&T committee is responsible for determining those
drug products and entities (if any) that shall be considered
therapeutic equivalents. The conditions and procedures for
dispensing a therapeutic alternative in place of the prescribed
drug shall be clearly delineated.
6. The institution shall make certain that its medical and nursing staffs are
informed about the existence of the formulary system, the procedures
governing its operation, and any changes in those procedures. Copies
of the formulary must be readily available and accessible at all times.
7. Provision shall be made for appraisal and use of drugs not included in
the formulary by the medical staff.

202

UNIVERSITYOFFLORDA JOURNAL OFLAW& I'UBLIC POLICY

[Vol. II

8. The pharmacist shall be responsible for specifications as to the quality,
quantity, and source of supply of all drugs, chemicals, biologicals, and
pharmaceutical preparations used in the diagnosis and treatment of
patients. When applicable, such products should meet the standards of
the United States Pharmacopeia.
Recommendation
A formulary system, based on these guiding principles, is important in
drug therapy in institutions. In the interest of better and more economical
patient care, its adoption by medical staffs is strongly recommended.

